Cypralis Limited
Research and experimental development on biotechnology · Cambridge
ActiveUnited KingdomIncorporated 2012Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · unknown scope
Net assets
−£1,232,088
Cash
£2,143
Turnover
—
Profit / loss
—
Current assets
£8,493
Creditors < 1 year
£1,242,331
Equity
−£1,232,088
Average employees
2
Balance-sheet trend
GBP · unknownTwo periods with a known, matching scope are needed for a trend.
Financial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2025-12-31GBP · unknown | 2024-12-31GBP · unknown | 2023-12-31GBP · unknown | 2022-12-31GBP · unknown | 2021-12-31GBP · unknown |
|---|---|---|---|---|---|
| Balance sheet | |||||
| Net assets | −£1,232,088 | −£1,125,044 | −£1,127,745 | −£962,241 | −£782,310 |
| Equity | −£1,232,088 | −£1,125,044 | −£1,127,745 | −£962,241 | −£782,310 |
| Assets | |||||
| Intangible assets | £1,750 | £1,750 | £3,500 | £3,500 | £3,500 |
| Current assets | £8,493 | £15,660 | £2,401 | £10,295 | £34,770 |
| Cash at bank | £2,143 | £1,361 | £402 | £7,912 | £30,808 |
| Liabilities | |||||
| Creditors within one year | £1,242,331 | £1,142,454 | £1,133,646 | £976,036 | £820,580 |
| Net current assets | −£1,233,838 | −£1,126,794 | −£1,131,245 | −£965,741 | −£785,810 |
| Assets less current liabilities | — | — | −£1,127,745 | −£962,241 | −£782,310 |
| People | |||||
| Average employees | 2 | 2 | 3 | 3 | 3 |
| Source evidence | View filing | View filing | View filing | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesNo charges available in our records.